Fuzuopali Uses, Dosage, Side Effects and more
Fuzuopali is under investigation in clinical trial NCT03863860 (A Trial of Maintenance Treatment With Fuzuopali Versus Placebo in Relapsed Ovarian Cancer Patients).
| Attribute | Details |
|---|---|
| Trade Name | Fuzuopali |
| Generic | Fluzoparib |
| Type | |
| Formula | C22H16F4N6O2 |
| Weight | Average: 472.404 Monoisotopic: 472.127086431 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
